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Cryptococcus gattii and C. neoformans cause pul-
monary and systemic cryptococcosis. Recently, C. gattii 
was recognized as a distinct pathogen of humans and 
animals. We analyzed information from 400 publications 
(1948–2008) to examine whether the fungus occurs glob-
ally. Known distribution of C. gattii is possibly limited be-
cause specialized reagents for differentiation from C. neo-
formans are not readily available and not always used, 
and environmental surveys are patchy. However, autoch-
thonous reports of C. gattii cryptococcosis have now been 
recognized from tropical and temperate regions. An ongo-
ing outbreak in western Canada strengthens the case that 
the range of the pathogen has expanded. A few studies 
have highlighted differences in cryptococcosis between C. 
gattii and C. neoformans. More than 50 tree species have 
yielded C. gattii especially from decayed hollows suggest-
ing a possible ecologic niche. This pathogen merits more 
attention so its environmental occurrence and role in cryp-
tococcosis can be accurately determined.
T
he yeast genus Cryptococcus has been recognized for 
>125 years, ﬁ  rst from fruit juice, milk, humans, soil, 
and pigeon droppings and from roosting areas (1). Although 
C. neoformans human infections were reported early in the 
1900s, the overall number of cryptococcosis cases was ex-
tremely low. Cryptococcosis cases increased in Africa dur-
ing 1947–1968, presumedly in association with the emer-
gence of AIDS in the Congo River basin (2); however, no 
independent conﬁ  rmation or laboratory data are available 
for this hypothesis. A unique variant, C. neoformans var. 
gattii, manifested by the unusual presence of elongated and 
cigar-shaped yeast morphology in cerebrospinal ﬂ  uid, was 
ﬁ  rst described in a Congolese Bantu boy (3,4).
Evans described and differentiated C. neoformans into 
3 serologic types (A, B, and C) by agglutination (5). Diag-
nosis of cryptococcosis progressed further with identiﬁ  ca-
tion of C. neoformans antibodies in body ﬂ  uids and devel-
opment of a latex agglutination test (1). Staib (6) developed 
a Guizotia abyssinica (Nigerseed) creatinine agar medium 
to distinguish pigment-producing C. neoformans from oth-
er Cryptococcus spp., which facilitated rapid screening of 
clinical and environmental samples for pathogenic C. neo-
formans isolates. A major advance in the classiﬁ  cation and 
taxonomy of C. neoformans occurred with the discovery of 
a heterothallic, bipolar mating involved in the production 
of the perfect state for C. neoformans var. gattii (serotypes 
B and C). It was termed Filobasidiella bacillispora and dif-
ferentiated from F. neoformans by production of smooth, 
elongate cylinder- to rod-shaped basidiospores (7).
Currently, C. neoformans is recognized as a species 
complex comprising C. neoformans var. grubii (serotype 
A) and C. neoformans var. neoformans (serotype D), 
which have distinct clinical manifestations and biological 
characteristics (1,8). C. gattii (serotypes B and D) was 
recognized as a species distinct from C. neoformans be-
cause of differences in basidiospore morphology, environ-
mental niches, morphologic features in vivo, limited mo-
lecular identity (55%–61% relatedness of DNA), multiple 
gene genealogies, unique random ampliﬁ  ed polymorphic 
DNA typing patterns, and inefﬁ  cient cross-species mating 
with the production of sterile progeny and no recombi-
nation (9). During the previous 2 decades, the increased 
pace of discovery produced a new appreciation of the 2 
major pathogenic species, namely, C. neoformans and C. 
gattii. This study aimed to critically examine published 
information about associated tree species, ecology, and 
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geographic occurrence of C. gattii to infer its environ-
mental distribution.
Methods
We comprehensively searched for published reports 
using the PubMed database (US National Library of Medi-
cine, National Institutes of Health) for 1948–2008. The 
keywords used in the search were Cryptococcus alone or 
in combination with Cryptococcus gattii;  Cryptococcus 
neoformans; Cryptococcus neoformans var. neoformans; 
Cryptococcus neoformans var. grubii; Cryptococcus neo-
formans serotype A, B, C, D, or AD; and cryptococcosis 
alone or in combination with human, pigeon, and animal. 
Additionally, we scrutinized reference lists in publications 
obtained from PubMed searches for citations that had not 
been captured with our choice of keywords in PubMed 
searches. These citations were easily obtained by repeat-
ing the search criteria in the Web of Science (Thompson 
Reuters) and Google Scholar.
One of us (D.J.S.) independently examined the title, 
abstract, methods, data tables and ﬁ  gures of publications 
identiﬁ  ed in the literature search. Information about Cryp-
tococcus isolates, serotype, mating type, molecular type, 
geographic location, and other relevant details were entered 
into a master spreadsheet. All publications with adequate 
documentation of C. gattii by >1 valid laboratory methods 
were regarded as acceptable for inclusion.
Results
From 400 potentially useful publications, we shortlist-
ed ≈200 and identiﬁ  ed 105 that provided information about 
primary isolations of C. gattii from clinical, veterinary, and 
environmental sources. Geographically, the reports origi-
nated from a total of 48 countries, although most reports 
concentrated on few areas (Table 1). Because a certain lev-
el of selection bias existed in this search process, we might 
have missed some relevant publications (10).
Distinguishing Features of C. gattii
C. gattii was easily and reliably differentiated from 
C. neoformans on creatinine dextrose bromthymol blue 
(CDB) medium. This work built on the discovery that C. 
neoformans can assimilate creatinine as sole source of car-
bon and nitrogen. Further modiﬁ  cation in CDB medium 
led to development of canavanine-glycine-bromthymol 
blue agar, which has since become the differential medium 
of choice (1,11,12). Unfortunately, the medium is still not 
widely used in diagnostic laboratories, most likely because 
of limited availability from commercial suppliers.
C. gattii populations can be distinguished by the pair-
ing of unknown isolates with compatible tester strains to 
distinguish MATα from MATa strains. MATα is most preva-
lent clinically and environmentally, and MATa is recovered 
less frequently (7,13,14). Four distinct C. gattii molecular 
subtypes (VGI, VGII, VGIII, and VGIV) have been rec-
ognized by PCR ampliﬁ  cation of genomic DNA by using 
bacteriophage M13 single-stranded primers. Genotypes 
VGI and VGII are prevalent worldwide, and VGIII and 
VGIV are less common (Figure). Serotypes B and C are 
randomly dispersed among the M13 molecular types. Fur-
ther molecular subtypes are now known to exist within the 
4 molecular types (15).
The VGI molecular genotype has been reported from 
many areas and from 2 C. neoformans–C. gattii hybrids re-
ported from Canada and the Netherlands (14,16). VGII has 
been reported from the Western Hemisphere, Australasia, 
Asia, and Africa and is reportedly the most fertile and viru-
lent of the strains responsible for infection in healthy and 
immunocompromised humans and animals. This strain also 
is associated with an ongoing outbreak of C. gattii crypto-
coccosis from Vancouver Island, British Columbia, Cana-
da (14). VGIII, which contains both serotypes B and C, is 
most commonly reported from South America but also is 
reported from North America, Central America, Austral-
asia, and Southern Asia. VGIV, frequently associated with 
serotype C, has been reported from Africa and South and 
Central America. Further experimental studies on VG gen-
otypes are needed to explain possible connections between 
distribution of various genotypes and propensity to cause 
cryptococcosis among exposed hosts.
C. gattii in Clinical and Environmental Specimens
Initially, reports of C. gattii originated from human 
clinical samples in tropical and subtropical regions, includ-
ing portions of Africa, Europe, Australia, the United States, 
and South America. This accounted for the long-held im-
pression that C. gattii is a tropical or subtropical pathogen 
(4,17,18). More recent clinical isolations from temperate 
regions in the United States, Canada, Europe, and Asia 
have greatly expanded the incidence areas of C. gattii (4). 
Accordingly, C. gattii has been reported from such diverse 
countries as Argentina, Austria, Canada, China, Congo, 
India, Italy, Japan, South Korea, the Netherlands, Spain, 
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Table 1. Number of publications per geographic region reporting 
isolation of Cryptococcus gattii
Region
Environmental
isolation
Clinical and 
veterinary 
isolation
Total no. 
reports
South America  18 12 30
Australia/New Zealand  8 16 24
North America  5 14 19
South-central Asia  9 9 18
Africa 2 12 14
Europe 3 12 15
Eastern Asia  0 6 6
Central America  1 5 6
Southeast Asia  0 3 3SYNOPSIS
South Africa, United Kingdom, United States, and Demo-
cratic Republic of Congo, and this list expands every year. 
Infections in domestic animals, such as goats, dogs, cats, 
and horses, are common in Australia, New Zealand, Canada, 
and Brazil (4,19,20). Additionally, infections are reported 
in migratory, water-dwelling animals, including porpoises 
and dolphins (21). C. gattii also was associated with native 
animals in Australia (koala, echidna), New Zealand (kiwi), 
Africa (cheetah), and Canada (squirrel) (14,19,22). Non-
native zoo animals (koala, ferret, tapir, cheetah, llama) and 
exotic birds (cockatoo and parrots) have been affected with 
cryptococcosis caused by C. gattii in Australia, Canada, 
the United States, and Cuba (23). Thus, C. gattii affects a 
wide variety of native and domestic animals in regions of 
known clinical presence. Because, in comparison with hu-
man clinical samples, veterinary samples are less frequent-
ly analyzed for and diagnosed with C. gattii infection and 
subsequently reported, we suggest that the actual infection 
rates of C. gattii in animal populations are possibly much 
higher than presently known.
Published literature on the environmental isolation of 
C. gattii is patchy, sporadic, and centered in geographic re-
gions reporting a high clinical incidence of C. gattii cryp-
tococcosis. This is true for Canada, South America, and 
Australia. However, in India the environmental prevalence 
of C. gattii appears more pervasive than the reported preva-
lence of the fungus in clinical specimens (Figure). The ﬁ  rst 
environmental isolation of C. gattii (serotype B) was re-
ported by Ellis and Pfeiffer from Eucalyptus trees in 1990 
(24) after unsuccessful attempts at environmental isolations 
from the same tree species in Oklahoma (18) and Califor-
nia (25). The ﬁ  rst environmental isolation of serotype C 
was reported in 1998 from almond trees in Colombia (26). 
Environmental sampling is much more limited than clini-
cal sampling because clinical isolates are a public health 
priority.
C. gattii serotype B is the most prevalent serotype in 
clinical and environmental samples (17,18). Curiously, C. 
gattii serotype C is a less common constituent of clinical 
and environmental isolations even though it is associated 
with AIDS patients and immunocompetent persons (27). C. 
gattii serotype C has been isolated from humans in clinical 
samples from India, the Western Hemisphere, and Africa 
(18,27). Although serotype C is rarely isolated from the en-
vironment, its most notable isolation occurred in association 
with detritus around nonnative almond trees in Colombia 
(26). More recent and extensive clinical surveys combining 
serotyping and molecular typing suggest that serotype C is 
less rare or restricted than previously thought (27). Future 
studies are unlikely to provide serotype information be-
cause the commercial typing reagents are no longer readily 
available, and thus genotypes will be the primary means to 
correlate strain characteristics with their environmental and 
clinical prevalence.
Existing reports and surveys of C. gattii from human 
clinical, veterinary, and environmental sources are patchy 
(Figure). Several areas between positive regions would 
most likely harbor the pathogen. Thus, C. gattii is likely 
to have a wider geographic distribution than documented. 
The environment has not been systematically explored to 
identify the source of C. gattii in the Congo River basin, 
where the ﬁ  rst deﬁ  nitive report of C. gattii emerged. Such 
environmental surveys are imperative in view of reports of 
C. gattii cryptococcosis from a number of African coun-
tries (3,17,27,28).
C. gattii and Trees
Ellis and Pfeifer reported the ﬁ  rst environmental iso-
lation of C. gattii in 1990 in Australia from wood, bark, 
leaves, and plant debris of Eucalyptus trees (24). Although 
Eucalyptus is present in many of the areas known to have 
C. gattii cryptococcosis, the actual isolation of C. gattii 
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Figure. Worldwide isolations of Cryptococcus 
gattii from human clinical, veterinary, and 
environmental sources. Circles indicate 
serotype information, diamonds indicate 
genotype information, and rectangles indicate 
hybrids between C. gattii and C. neoformans. 
Existing reports and survey are patchy, and 
several areas between positive regions share 
tree species (Table 2) and climatic conditions 
and would most likely harbor the pathogen. 
Thus,  C. gattii is likely to be more widely 
distributed than documented.Global Occurrence of C. gattii
from Eucalyptus trees is rare outside Australia, despite 
extensive sampling. Imported Eucalyptus has not been 
associated with the environmental presence of C. gattii 
in Spain, central Africa, or Canada, and most Eucalyptus 
trees tested in Papua New Guinea, Egypt, and Italy were 
negative for C. gattii. Furthermore, early environmental 
surveys for C. gattii in imported Eucalyptus spp. rarely 
included other local tree species for testing (4). Although 
understandable, this was unfortunate because C. gattii is 
now known to have extensive associations with other tree 
species.
Evidently, C. gattii is established ecologically in trees 
other than Eucalyptus in many parts of the world, as sup-
ported by C. gattii association with native trees in Canada, 
Brazil, Colombia, India, and Argentina (Figure). C. gattii 
has been reported from 54 tree species; most (77%) are an-
giosperms; gymnosperms account for 23% of positive spe-
cies (Table 2). Gymnosperms and angiosperms can develop 
decayed hollows, which differ in biochemical composition, 
available nutrients, presence of water, microbial communi-
ties, and fungal associations (29). C. gattii exhibits associa-
tions with the gymnosperms Abies spp., Arbutus menziesii 
var. menziesii, Cedrus spp., Abies grandis, Picea spp., Pi-
nus spp., Pseudotsuga menziesii var. menziesii, and Thuja 
plicata in Canada; Pinus radiate (Monterey pine) and Cu-
pressus lusitanica in Colombia; and Cedrus deodara and 
Cupressus sempervirens in Argentina. Angiosperms other 
than Eucalyptus spp. have been reported positive for C. 
gattii from North America, South America, Africa, and In-
dia. Like Eucalyptus spp., other angiosperm tree species re-
ported as hosts for C. gattii have been extensively exported 
from their native areas (Table 2). Two prominent examples 
are Ficus spp. and Terminalia spp. (almond) trees. Ficus 
spp. are widely distributed in the tropics and subtropics, 
and many are exported as ornamentals. Ficus spp. have 
been recorded as C. gattii hosts in Brazil and Colombia but 
not in other regions (30).
C. gattii vis-à-vis C. neoformans
Cryptococcosis due to C. gattii is unlikely to be rec-
ognized in the laboratory without heightened awareness 
and sustained effort to differentiate these 2 closely related 
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Table 2. Tree species recorded as testing positive for Cryptococcus gattii
Location Species (common name)  Native and exported tree ranges 
Argentina Acacia visco (arca), Cedrus deodara* (deodar cedar), Cupressus 
sempervirens* (Mediterranean cypress), Eucalyptus microcorys
(tallowwood), Tipuana tipu (rosewood), Ulmus campestris (English elm) 
Australia, Africa, Asia, Britain, Canada, 
Central America, England, Europe, 
Japan, South America, United States 
Australia  Angophora costata (smooth bark apple), E. blakelyi (Blakely's red gum),
E. camaldulensis (red river gum), E. gomphocephala (tuart tree),
E. grandis (rose gum), E. microcorys (tallowwood), E. rudis (flood gum),
Eucalyptus spp., E. tereticornis (forest red gum), E. tetrodonta (Darwin 
stringybark), Syncarpia glomulifera (turpentine) 
Australia, Africa, Asia, Caribbean, Hawaii, 
Indonesia, New Zealand, Papua New 
Guinea, United States, South America, 
US Virgin Islands, British Virgin Islands 
Brazil  Adenanthera pavonina (circassian seed), Cassia grandis (carao), 
Erythrinia velutina (coral tree), E. camaldulensis (red river gum),  
E. microcorys (tallowwood), Eucalyptus spp., Ficus spp.,
Guettarda acrena, Moquilea tomentosa (pottery tree) 
Australia, Africa, Asia, Caribbean, Central 
America, Fiji, New Zealand, South 
America, United States, US Virgin 
Islands, British Virgin Islands 
Canada Abies grandis* (grand fir), Abies spp.* (fir), Acer spp.(maple), Alnus rubra
(red alder), Aluns spp. (alder), Arbutus menziesii* (Pacific madrone),
Cedrus spp.* (cedar), Picea spp.* (spruce), Pinus spp.* (pine), Prunus 
emarginata (bitter cherry), Pseudotsuga menziesii* (coastal Douglas fir),
Quercus garryana (Garry oak), Thuja plicata* (western red cedar) 
Australia, Europe, New Zealand, North 
America, South America 
Colombia Acacia decurrens (black wattle), Coussapoa sp, Croton bogotanus,  
C. funckians (C. gossypiifolius), Cupressus lusitanica* (Mexican cypress), 
E. camaldulensis (red river gum), E. globulus (Tasmanian blue gum), 
Ficus soatensis (rubber Savanna), Pinus radiata* (Monterey pine), 
Terminalia catappa (almond) 
Africa, Asia, Australia, British Isles, 
Canada, Caribbean, Costa Rica, Europe, 
Costa Rica, Hawaii, Indonesia, 
Mediterranean region, Mexico, New 
Zealand, Pacific Islands, Papua New 
Guinea, Japan, United States, South 
America, US Virgin Islands, British Virgin 
Islands
India Acacia nilotica (thorn tree), Azadirachta indica (neem tree), Cassia fistula 
(golden shower tree), Cassia marginata, E. camaldulensis (red river gum),
E. citriodora (lemon-scented gum), Eucalyptus spp., Mangifera indica
(mango), Manilkara hexandra (margosa), Mimusops elengi (bullet wood or 
Indian madlar tree), Pithecolobium dulce (Manila tamarind), Polyalthia
longifolia (Indian mast tree), Syzygium cumini (java plum), Tamarindus 
indica (tamarind), Terminalia arjuna (arjuna) 
Africa, Asia, Australia, Caribbean, Central 
America, Hawaii, Indonesia, Malaysia, 
Pacific Islands, Philippines, Portugal, 
South. America, New Zealand, United 
States, US Virgin Islands, British Virgin 
Islands
Egypt, Italy, 
Mexico, 
United States 
E. camaldulensis (red river gum)  Africa, Australia, Caribbean, New 
Zealand, United States, South America, 
South Asia, US Virgin Islands, British 
Virgin Islands 
*Gymnosperm tree species. SYNOPSIS
pathogens. Given the much more recent recognition of C. 
gattii, historical reports are likely to mention only C. neo-
formans; this is a major consideration in evaluating histori-
cal publications on cryptococcosis due to C. gattii. Pigeon 
droppings are a known ecologic niche for C. neoformans 
because the pathogen is predominantly isolated from avian 
environments or areas contaminated with avian feces (1). 
Thus, urban dwellings frequented by pigeons and contain-
ing accumulated pigeon droppings are an important reser-
voir for human and animal infections.
Pigeons are not known to acquire symptomatic disease 
but can carry yeast on feathers, skin, crops, or cloaca (1). 
Other animals reported positive for C. neoformans include 
macaw, swan, parakeet, Guenon monkey, fox, potoroo, and 
sheep (1). Thus, exotic and migratory birds and domestic 
and wild animals can be carriers or susceptible hosts for 
C. neoformans. The overwhelming association with avian 
droppings and environment, especially pigeons, sets C. 
neoformans apart from C. gattii. The ecologic niches for C. 
neoformans and C. gattii appear to be distinct.
Few reports exist of isolations of C. neoformans and 
C. gattii from the same habitats with the recognitions of 
natural hybrids between the 2 species. For instance, C. 
neoformans and C. gattii have been isolated from same 
sources, such as Eucalyptus spp. or Syzygium cumini trees 
or bird feces (1,30,31). C. grubii association with trees 
might represent fecal contamination by birds inhabiting 
these trees. Hybrid strains have been isolated from sam-
ples of bird feces in urban areas of South America and 
from patient samples obtained from the Netherlands and 
Canada (16). The existence of these hybrid strains sug-
gests that at least in some parts of the world C. neofor-
mans and C. gattii occupy either the same ecologic niche 
or closely overlapping areas.
Discussion
We suggest that C. gattii is an environmental patho-
gen with a specialized ecologic niche on the basis of accu-
mulated reports of its widespread isolation from domestic 
and native animals, clinical presence in temperate cli-
matic regions, increasing reports of isolations from native 
trees in temperate regions, and recapitulation of life cycle 
in association with plant material. The characteristics of 
such environmental pathogens include absence of any 
recognized animal host and maintenance of virulent traits 
by speciﬁ  c environmental associations. This concept has 
been well developed for a number of other environmental 
pathogens, such as Mycobacterium ulcerans (32) and Bur-
kholderia spp. (33). The 54 tree species recorded positive 
for C. gattii are native to tropical, subtropical, and tem-
perate regions of the world. Additionally, many of these 
trees are more widely distributed than their documented 
native range(s) indicate because of extensive exportation 
and cultivation, which suggest further expansion of the 
known range of C. gattii.
A corollary of this environmental distribution of the 
fungus is the diagnosis of autochthonous C. gattii crypto-
coccosis in native and domestic animals in Europe, Africa, 
Australia and New Zealand, and the Western Hemisphere, 
suggesting that habitats of many of these animals overlap 
ecologic niches with the fungus (19). A consistent feature 
of the association of C. gattii with trees is isolation of the 
fungus from decayed hollows of angiosperm and gymno-
sperm species (24,30). Decayed wood hollows develop 
slowly and are distinct ecologic niches inhabited by spe-
cialized microbial communities (29). Microbes that use 
wood or decayed hollows require specialized adaptations 
to inhabit this ecologic niche, which also offers a refuge 
from deleterious biotic and abiotic factors. Decayed hol-
lows are characteristics of mature trees and thus occur most 
frequently in forested regions or rural to semirural areas 
with mature trees (29). This pattern is consistent with rec-
ognition of C. gattii cryptococcosis in Canada, Australia, 
Africa, Asia, and parts of South America. In some instanc-
es, especially in temperate areas, C. gattii has been isolated 
from trees in parks, on college campuses, and in zoos and 
animal refuges (24,31). Recent studies provide additional 
evidence for this specialized ecologic niche in trees and 
tree hollows by documenting long-term associations of C. 
gattii with trees, including seasonal variations in its isola-
tion, and genetic recombination indicative of sexual and/or 
asexual mating in association with trees and tree hollows 
(13). An experimental study has recapitulated the sexual 
life cycle of the fungus in the laboratory on Arabidopsis 
thaliana and Eucalyptus spp. seedlings with production of 
easily airborne sexual spores (basidiospores) thus support-
ing the universal dispersal hypothesis, which suggests that 
most of the free-living microbial eukaryotes are likely to be 
globally distributed (34).
The association of C. gattii with woody materials 
distinguishes this species from C. neoformans niche in 
soil and pigeon droppings. Several publications provide 
additional evidence for this inference: 1) Escandon dem-
onstrated that C. gattii can survive in live almond trees 
and can contaminate the soil in immediate surrounding 
(35); 2) mating has been associated with live plants and 
wood (13,36); and 3) positive soil sample are mostly iso-
lated near positive trees and have been contaminated with 
woody plant debris.
C. gattii potentially can be dispersed through export of 
trees and woody products, air currents, water currents, and 
biotic sources, such as birds, animals, and insects. The abil-
ity of C. gattii to associate with vesicular elements in wood 
blocks, to survive in the vasculature of live almond trees, 
and to spread into soil (35,37) suggests that the pathogen 
can spread through the exportation of wood and trees (24). 
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Historically, Eucalyptus trees have been implicated in the 
spread of C. gattii to different areas in the world (24). Re-
cently,  Pinus radiate,  Cedrus deodara,  Cupressus sem-
pervirens, Cupressus lusitanica, and Terminalia catappa 
(almond) have been recognized as C. gattii hosts; these 
trees have been widely exported from their native ranges as 
ornamental or commercially valuable trees. The evidence 
for C. gattii dispersal by wind and air currents is limited, 
but fungal isolations from air samples have been obtained 
around positive trees in Canada and India.
The following observations suggested dispersal of C. 
gattii in water or water currents: 1) naturally infected por-
poises and dolphins have been identiﬁ  ed, 2) the fungus has 
been isolated from natural freshwater and saltwater sam-
ples in British Columbia and from contaminated water in 
habitats of captive animals, and 3) C. gattii can survive in 
water in vitro for long periods (21). Multiple reports have 
suggested that birds and animals could play a role in disper-
sal of C. gattii to geographic areas presently uninhabited by 
C. gattii. Isolation of the fungus from psittacine bird excre-
ment in South America is suggestive because many of these 
birds ﬂ  y long distances and are migratory or are exported 
as exotic pets or exhibit items for zoos (31). Other native 
animals that could help in C. gattii spread include koalas in 
Australia (22), squirrels and porpoises in the Paciﬁ  c North-
west (19), and dolphins (21) in North America.
C. gattii is likely to be acquired in areas where ma-
ture trees are abundant either in forested or rural to semi-
urban settings. We derived this conclusion from published 
clinical reports on C. gattii cryptococcosis in Aborigines in 
Australia, native Africans in the Congo River basin, Cana-
dians who visited parks and forests on Vancouver Island, 
and a Spanish farmer and Italian farmer (38,39). A com-
mon theme among these clinical cases is presence of and 
human exposure to mature trees. Recovery of identical C. 
gattii strains from environmental sources from Canada and 
human clinical specimens from Italy strongly suggest that 
the point source of infection is the immediate vicinity of 
patients’ residences (14,39). Association of C. gattii with 
decayed woody hollows, bark, and tree debris also suggests 
a role for mature trees (19,24).
Infections reported in domestic and wild animals in 
Australia, New Zealand, Africa, Spain, the United States, 
and Canada provide another important clue to risk areas 
for C. gattii acquisition (19). Overwhelmingly, these infec-
tions are reported from animals that either reside in or are 
exposed to areas with an abundance of mature trees. This 
situation is somewhat analogous to the fungus Blastomy-
ces dermatitidis, another elusive primary pathogen, which 
causes blastomycosis. Some similarities in characteristics 
include clustered infection patterns in humans and mam-
mals; increases in exposure risk from outdoor activities, and 
restricted and infrequent environmental isolations (40).
Conclusions
C. gattii is a globally established primary fungal 
pathogen with a specialized ecologic niche on trees and in 
hollows of trees. Future epidemiologic studies and envi-
ronmental surveys are likely to reveal the extent of C. gat-
tii prevalence in different environments especially in areas 
with known incidence of cryptococcosis but no reported 
isolations of C. gattii. Such information will be helpful in 
devising strategies to manage potential outbreaks of crypto-
coccosis. More clinical studies are also needed to follow up 
the course and outcome of C. gattii cryptococcosis, the sa-
lient point by which this fungus can be differentiated from 
the disease caused by C. neoformans, and any changes in 
patient management strategies.
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